COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review
Author:
Publisher
Baishideng Publishing Group Inc.
Reference73 articles.
1. Clinical Characteristics of Coronavirus Disease 2019 in China
2. Age-specific mortality and immunity patterns of SARS-CoV-2
3. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
4. Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
5. COVID-19: consider cytokine storm syndromes and immunosuppression
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights;Clinical and Experimental Medicine;2024-06-04
2. Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study;Oncohematology;2024-01-15
3. The effect of SARS-CoV-2 infection on cancer: Clinical correlation and potential pathological mechanism;Features, Transmission, Detection, and Case Studies in COVID-19;2024
4. Spontaneous Remission of High-Grade Non-Hodgkin Lymphoma After SARS-CoV-2 Infection;Clinical Nuclear Medicine;2023-11-29
5. Outcomes of COVID‐19 in patients with lymphomas participating in registered clinical trials: A real‐world study from China in the Omicron outbreak era;Cancer Medicine;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3